Prof. Yair Herishanu

Professor Yair Herishanu is widely regarded as one of Israel’s leading specialists in blood disorders. At his private clinic in TAMC, Tel Aviv, he meets patients from Israel and abroad, offering consultations and treatment plans that are adapted to each person’s needs. In 2021, he was listed among the Forbes “Top Doctors in Israel,” a recognition of both his experience and his patient-centered approach.

A major part of Professor Herishanu’s work is devoted to chronic lymphocytic leukemia (CLL). Before starting any treatment, he carefully reviews each case: recent lab tests, any other medical issues, and the genetic profile of the disease. From there, he outlines a plan that might involve close observation for a time, targeted medications, or, when indicated, chemotherapy. For certain cases, he also performs bone marrow transplantation, including less intensive “mini-transplants” that are easier on the body.

Over the years, he has combined his clinical work with academic roles and currently teaches hematology at Tel Aviv University.

Alongside his practice, he has published more than 100 scientific articles. His work often looks at innovative treatments such as CAR-T therapy, new approaches to immunotherapy in CLL, and how blood cancer patients respond to infections like COVID-19 and to vaccination.